Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lindsey H.M. te Brake"'
Autor:
Jodie A. Schildkraut, Jordy P.M. Coolen, Carolien Ruesen, Jeroen J.M.W. van den Heuvel, Laura Edo Aceña, Heiman F.L. Wertheim, Robert S. Jansen, Jan B. Koenderink, Lindsey H.M. te Brake, Jakko van Ingen
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 34, Iss , Pp 161-165 (2023)
ABSTRACT: Objectives: Mycobacterium avium (M. avium) complex bacteria cause opportunistic infections in humans. Treatment yields cure rates of 60% and consists of a macrolide, a rifamycin, and ethambutol, and in severe cases, amikacin. Mechanisms of
Externí odkaz:
https://doaj.org/article/428d96b8d247445583aa3ae8c8c94a1b
Autor:
Suzaan Marais, Fiona V Cresswell, Raph L. Hamers, Lindsey H.M. te Brake, Ahmad R. Ganiem, Darma Imran, Ananta Bangdiwala, Emily Martyn, John Kasibante, Enock Kagimu, Abdu Musubire, Kartika Maharani, Riwanti Estiasari, Ardiana Kusumaningrum, Nadytia Kusumadjayanti, Vycke Yunivita, Kogieleum Naidoo, Richard Lessells, Yunus Moosa, Elin M. Svensson, Katherine Huppler Hullsiek, Rob E. Aarnoutse, David R. Boulware, Reinout van Crevel, Rovina Ruslami, David B. Meya
Publikováno v:
Wellcome Open Research, Vol 4 (2020)
Background: Tuberculous meningitis (TBM), the most severe form of tuberculosis (TB), results in death or neurological disability in >50%, despite World Health Organisation recommended therapy. Current TBM regimen dosages are based on data from pulmon
Externí odkaz:
https://doaj.org/article/d06cf107e8164549a460f56a6aa07fa4
Autor:
Celine Bolwerk, Cecile Magis-Escurra, Wouter Hoefsloot, Laurens F. M. Verscheijden, Arjan van Laarhoven, David M. Burger, Jakko van Ingen, Jan B. Koenderink, Frans G. M. Russel, Reinout van Crevel, Rob E. Aarnoutse, Martin J. Boeree, Rovina Ruslami, Petra H.H. van den Broek, Carlijn H. C. Litjens, Lindsey H.M. te Brake, Elin M. Svensson, Jeroen J. M. W. van den Heuvel, Saskia Kuipers, Rick Greupink
Publikováno v:
Journal of Clinical Pharmacology and Journal of New Drugs, 62, 3, pp. 385-396
Journal of Clinical Pharmacology and Journal of New Drugs, 62, 385-396
Journal of Clinical Pharmacology and Journal of New Drugs, 62, 385-396
Contains fulltext : 248642.pdf (Publisher’s version ) (Open Access) Moxifloxacin has an important role in the treatment of tuberculosis (TB). Unfortunately, coadministration with the cornerstone TB drug rifampicin results in suboptimal plasma expos
Autor:
Rovina Ruslami, Reinout van Crevel, David M. Burger, Nanny N M Soetedjo, Eleonora W. J. van Ewijk-Beneken Kolmer, Resvi Livia, Rob E. Aarnoutse, Bachti Alisjahbana, Prayudi Santoso, Vycke Yunivita, Lindsey H.M. te Brake, Jan B. Koenderink
Publikováno v:
Clinical Pharmacology and Therapeutics, 105, 730-737
Clinical Pharmacology and Therapeutics, 105, 3, pp. 730-737
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics, 105, 3, pp. 730-737
Clinical Pharmacology and Therapeutics
The pharmacokinetic (PK) and clinical implications of combining metformin with rifampicin are relevant to increasing numbers of patients with diabetic tuberculosis (TB) across the world and are yet unclear. We assessed the impact of rifampicin on met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c34545c9b21a6344f27b6a69dc264faa
http://hdl.handle.net/2066/202131
http://hdl.handle.net/2066/202131
Autor:
Erik van den Hombergh, Eleonora W. J. van Ewijk-Beneken Kolmer, Rob E. Aarnoutse, Lindsey H.M. te Brake, Marga Teulen, Nielka E. van Erp
Publikováno v:
Journal of Chromatography. B, 1063, pp. 42-49
Journal of Chromatography. B, 1063, 42-49
Journal of Chromatography. B, 1063, 42-49
Contains fulltext : 176986.pdf (Publisher’s version ) (Open Access) Rifampicin is the most important antibiotic in use for the treatment of tuberculosis (TB). Preclinical and clinical data suggest that higher doses of rifampicin, resulting in dispr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69f5c215bfb73ecff708e2db7770aed6
https://hdl.handle.net/2066/176986
https://hdl.handle.net/2066/176986
Autor:
Jurriaan E. M. de Steenwinkel, Gerjo J. de Knegt, Jan B. Koenderink, David M. Burger, Frans G. M. Russel, Lindsey H.M. te Brake, Jeroen J. M. W. van den Heuvel, Rob E. Aarnoutse
Publikováno v:
Tuberculosis, 96, 150-157. Churchill Livingstone
Tuberculosis, 96, 150-7
Tuberculosis, 96, pp. 150-7
Tuberculosis, 96, 150-7
Tuberculosis, 96, pp. 150-7
Contains fulltext : 167529.pdf (Publisher’s version ) (Closed access) BACKGROUND: Multiple-drug therapy for tuberculosis (TB) and TB-associated co-morbidity increase the likelihood of drug-drug interactions (DDIs). Inhibition of membrane transporte
Autor:
Rogier Donders, Carolien Ruesen, Sofiati Dian, Ahmad Rizal Ganiem, David M. Burger, Lindsey H.M. te Brake, Rovina Ruslami, Rob E. Aarnoutse, Reinout van Crevel
Publikováno v:
International Journal of Antimicrobial Agents, 45, 496-503
International Journal of Antimicrobial Agents, 45, 5, pp. 496-503
International Journal of Antimicrobial Agents, 45, 5, pp. 496-503
Item does not contain fulltext Recent data suggest that intensified antimicrobial treatment may improve the outcome of tuberculous meningitis (TBM). Considering that drug exposure is the intermediate link between dose and effect, we examined the conc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b538dd473346ee0ea00c6f36ecf01e85
https://doi.org/10.1016/j.ijantimicag.2014.12.027
https://doi.org/10.1016/j.ijantimicag.2014.12.027